Sphere, the technology company behind the AI platform OrgBrain, has announced a new partnership with the National Health Council (NHC) aimed at helping healthcare organizations
Peregrine Health, a national company that focuses on offering behavioral health services in areas where they are not easily available, has announced a bigger partnership
LateralCare is excited to be featured in Health Information: Making Every Patient’s Story Matter, a new digital series created by the American Health Information Management
Welcome to your Daily Dose of Health Tech Innovation!Stay ahead with the latest breakthroughs revolutionizing healthcare—from AI diagnostics to remote care solutions.We bring you expert-curated insights,
LyfeSci Research & Innovation, a newly established Contract Research Organization (CRO) led by physicians, is officially launching with a clear mission to transform the clinical
Amalgam Rx, Inc., a recognized leader in AI-powered healthcare decision-making, has announced the publication of two peer-reviewed studies that validate its Medical-Grade AI framework. The
Healthier Capital, Norwest, Define Ventures and other new strategic investors back Hyro as demand soars for healthcare-native AI agents across providers, payers and clinics Hyro,
Pretorian Labs, LLC, one of the fastest-growing high-complexity labs in the country, has entered into a strategic partnership with Massillon Community Health (MCH) to launch
Polpharma Biologics has officially launched Ranivisio PFS, a ranibizumab biosimilar in a pre-filled syringe format, now available to patients and healthcare providers in France. This
StratifAI, an AI-driven precision oncology company behind the Polaris platform, has been selected to participate in the Memorial Sloan Kettering iHub Challenge 2025 Cohort. This
Nationally Recognized Medical Oncologist Will Lead Efforts to Further Strengthen ConcertAI’s Coordination with the Oncology Community and Focus on Patient-Centered Innovation ConcertAI, a leading provider
Access Vascular, Inc., a company focused on developing advanced vascular access devices, has received clearance from the U.S. Food and Drug Administration for a new
